Your browser doesn't support javascript.
loading
Real-world clinical outcomes of patients with myelofibrosis treated with ruxolitinib: a medical record review.
Passamonti, Francesco; Heidel, Florian H; Parikh, Rohan C; Ajmera, Mayank; Tang, Derek; Nadal, Jose Alberto; Davis, Keith L; Abraham, Pranav.
Afiliação
  • Passamonti F; Department of Hematology, University of Insubria, Varese, 21100, Italy.
  • Heidel FH; Internal Medicine C, University Medicine Greifswald, Greifswald, 17475, Germany.
  • Parikh RC; Health Economics, RTI Health Solutions, Research Triangle Park, NC 27709, USA.
  • Ajmera M; Health Economics, RTI Health Solutions, Research Triangle Park, NC 27709, USA.
  • Tang D; Hematology, Bristol Meyers Squibb, Lawrenceville, NJ 08648, USA.
  • Nadal JA; Hematology, Bristol Meyers Squibb, Lawrenceville, NJ 08648, USA.
  • Davis KL; Health Economics, RTI Health Solutions, Research Triangle Park, NC 27709, USA.
  • Abraham P; Hematology, Bristol Meyers Squibb, Lawrenceville, NJ 08648, USA.
Future Oncol ; 18(18): 2217-2231, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35388710
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mielofibrose Primária Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article